Biosimilar Testing and Development Services Market Insights Video

According to Cognitive Market Research, the global Biosimilar Testing and Development Service market size is USD 2651.00 million in 2024. It will expand at a compound annual growth rate (CAGR) of 12.50% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 1060.40 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.7% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 795.30 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 609.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.5% from 2024 to 2031.
• Latin America had a market share for more than 5% of the global revenue with a market size of USD 132.55 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.9% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 53.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.2% from 2024 to 2031.
• The Pharmacokinetics Assay held the highest Biosimilar Testing and Development Service market revenue share in 2024.